Company intelligence / Profile preview

Novocardia

Ownership: Private
Development stage: Commercial

Overview

Novocardia operates a nationwide network of cardiologists and delivers value-based cardiovascular care, aiming to improve patient outcomes and reduce costs through advanced analytics, technology, and evidence-based medicine. The company has demonstrated reductions in ER visits, readmissions, and cost of care compared to national averages.

Therapeutic areas: Cardiovascular
Industry: Non-Academic Healthcare

Partnerships

Primary care groupsPayersPhysician partners

Beyond the preview

Go deeper on Novocardia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novocardia.

Explore the full profile